FDA/Scottish Government deal raises members’ pay and protects jobs
Catuncia / Shutterstock.com
The FDA has secured on-call payment, pay rises and job security for Scottish Government staff.
Following union negotiations, FDA members working across the Scottish Government voted to accept the proposed 2019/2020 pay offer. This included a 3% consolidated pay rise for staff on the B3, C1, C2 and C3 scale maxima, and further non-consolidated payments for all staff on pay range maxima.
Meanwhile, staff below their pay range maximum will receive full progression to the next point of their pay scale.
The offer also featured a commitment to enforce no compulsory redundancies for the duration of the pay deal, and the introduction of a new rate of payment for staff required to be on call.
National Officer Allan Sampson said: “I am delighted that members have again voted to accept the pay offer for Scottish Government Main bargaining unit, securing for the second year in succession an above-inflation pay rise for our talented and hard-working members, and delivering upon ministers commitments to restoration of pay across the Scottish Sector.”
FDA Scottish Government Branch rep Jules Goodlet-Rowley, who worked alongside Sampson on the negotiations, believe the deal is “is the best that could have been achieved under the current conditions.” “Looking forward,” she said, “I am interested in how we continue the conversation with Scottish Government and our ministers to meet the expectations of our members while securing a fair deal for everyone”.
Following union negotiations, FDA members working across the Scottish Government voted to accept the proposed 2019/2020 pay offer. This included a 3% consolidated pay rise for staff on the B3, C1, C2 and C3 scale maxima, and further non-consolidated payments for all staff on pay range maxima.
Meanwhile, staff below their pay range maximum will receive full progression to the next point of their pay scale.
The offer also featured a commitment to enforce no compulsory redundancies for the duration of the pay deal, and the introduction of a new rate of payment for staff required to be on call.
National Officer Allan Sampson said: “I am delighted that members have again voted to accept the pay offer for Scottish Government Main bargaining unit, securing for the second year in succession an above-inflation pay rise for our talented and hard-working members, and delivering upon ministers commitments to restoration of pay across the Scottish Sector.”
FDA Scottish Government Branch rep Jules Goodlet-Rowley, who worked alongside Sampson on the negotiations, believe the deal is “is the best that could have been achieved under the current conditions.” “Looking forward,” she said, “I am interested in how we continue the conversation with Scottish Government and our ministers to meet the expectations of our members while securing a fair deal for everyone”.
Related News
-
78% of civil servants believe office attendance mandate has failed, finds new FDA report
A new report published by the FDA finds that the government’s 60% office attendance mandate has failed to deliver on any of its own objectives to boost productivity, improve collaboration, and help younger workers.
-
Scotland’s justice system needs ‘sustained further investment’
FDA National Officer Allan Sampson has warned that the “increase in funding and staffing” for the Crown Office and Procurator Fiscal Service (COPFS) “hasn’t been enough to tackle the long-term impact of a decade of underfunding dating back to 2010”.
-
Northern Ireland AGM 2025: A growing Section going from strength to strength
The FDA welcomed members from its Northern Ireland Section to this year’s AGM, featuring a keynote address from former Head of the NICS Sir David Sterling.